Ke Dong, MD
5
1
1
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
The Effect of tDCS Combined With TMS on Cognitive Impairment and Motor Function After Stroke
Role: lead
Dual-site Cross-frequency Coupled Transcranial Electrical Stimulation Modulates Working Memory of Patients With Post-stroke Cognitive Impairment
Role: lead
Accelerated Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease and Secondary Parkinson's Syndrome
Role: lead
The Effect of Dual-target tACS Combined With Speech Training on Repetition Disorder After Stroke
Role: lead
tACS Modulates Speech and Cognitive Impairments in People With PD by Targeting the Medial Frontal Cortex
Role: lead
All 5 trials loaded